Long Term Open Follow-up With H376/95 vs. Warfarin


Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to evaluate tolerability of long-term treatment with ximelagatran compared to standard treatment with warfarin. Trial Stopped: Melagatran/ximelagatran was withdrawn from the market and clinical development in February 2006 in the interest of patient safety.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 November 2010.

1 Aug 1999 13 Sep 2005 1 Jun 2004 1 Apr 2006 1 Nov 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment


Not available